Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 19;22(1):51.
doi: 10.1186/s12987-025-00661-w.

Idiopathic normal pressure hydrocephalus: associations between CSF biomarkers, clinical symptoms, and outcome after shunt surgery

Affiliations

Idiopathic normal pressure hydrocephalus: associations between CSF biomarkers, clinical symptoms, and outcome after shunt surgery

Majd Saadaldeen et al. Fluids Barriers CNS. .

Abstract

Background: The neurochemical alterations in cerebrospinal fluid (CSF) associated with the typical symptomatology in idiopathic normal pressure hydrocephalus (iNPH) and their association with outcome after shunt surgery are unsettled.

Aim: To explore associations between concentrations of CSF biomarkers reflecting amyloid- and tau pathology, neuronal degeneration as well as astrocytic activation and the characteristic symptomatology in iNPH and to examine whether these biomarkers can predict the postoperative outcome in all patients and in patients without evidence of Alzheimer's disease (AD) pathology.

Methods: This explorative study included 81 patients diagnosed with iNPH at the Hydrocephalus research unit, Sahlgrenska. Symptoms were assessed using the iNPH-scale and standardized clinical tests measuring gait, balance, cognition and urinary incontinence before and median 8 months after shunt surgery. Pre-operative lumbar CSF concentrations of Aβ38, Aβ40, Aβ42, ratio Aβ42/Aβ40, sAPPα, sAPPβ, T-tau, P-tau, MCP-1, and NFL were analyzed. A low Aβ42/Aβ40 ratio defined patients with AD pathology. Correlation and regression analyses between biomarker concentrations and clinical symptoms at baseline as well as postoperative change in symptoms after surgery, were performed.

Results: Higher NFL correlated with more pronounced impairment in all clinical tests, i.e. included measures of gait, balance, cognition and urinary incontinence (rp=0.25-0.46, p < 0.05). Higher T-tau and P-tau correlated with poorer performance in cognitive tests (rp=0.26-0.39, p < 0.05). No biomarker could differentiate between improved and unimproved patients in the whole sample or in AD-pathology negative patients. Low ratio Aβ42/Aβ40 lacked predictive value. A higher preoperative P-tau was weakly correlated with less pronounced overall clinical improvement (rp = -0.238, p = 0.036).

Conclusions: Axonal degeneration, as indicated by elevated NFL, is probably involved in the generation of the full iNPH tetrade of symptoms and tau pathology more specifically with iNPH cognitive impairment. No CSF biomarker could identify shunt responders. CSF evidence of Alzheimer pathology should not be used to exclude patients from shunt surgery.

Keywords: Biomarkers; CSF; Cerebrospinal fluid; Idiopathic normal pressure hydrocephalus; Outcome; Symptoms.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study was conducted in accordance with the Declaration of Helsinki and was approved by the Regional Ethical Review Board in Gothenburg (DNR 020 − 07). Written informed consent to inclusion in the study was given by all patients or their next of kin. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Scatter plot for NFL and the total iNPH scale score before surgery. Rp= -0.375. Nota bene: logarithmic values for NFL
Fig. 2
Fig. 2
Scatter plot for P-tau and the overall outcome score defined as postoperative change in total iNPH scale score. rp=-0.238. Nota bene: logarithmic values for P-tau

Similar articles

References

    1. Adams RD, et al. Symptomatic occult hydrocephalus with normal cerebrospinal-fluid pressure. A treatable syndrom. N Engl J Med. 1965;273:117–26. - PubMed
    1. Jaraj D, et al. Prevalence of idiopathic normal-pressure hydrocephalus. Neurology. 2014;82(16):1449–54. - PMC - PubMed
    1. Constantinescu C, et al. Prevalence of possible idiopathic normal pressure hydrocephalus in Sweden: A Population-Based MRI study in 791 70-Year-Old participants. Neurology. 2024;102(2):e208037. - PMC - PubMed
    1. Marmarou A, et al. Guidelines for management of idiopathic normal pressure hydrocephalus: progress to date. Acta Neurochir Suppl. 2005;95:237–40. - PubMed
    1. Klinge P, Hellstrom P, Tans J, Wikkelso C. One-year outcome in the European multicentre study on iNPH. Acta Neurol Scand. 2012;126(3):145–53. - PubMed

LinkOut - more resources